Fig. 3From: Clopidogrel treatment may associate with worsening of endothelial function and development of new digital ulcers in patients with systemic sclerosis: results from an open label, proof of concept studyEffects of clopidogrel on clinical outcomes. Clopidogrel treatment does not have any significant impact on clinical outcomes (MRSS (a), FVC (b), DLco (c) and EGFR (d)) in patients with SScBack to article page